BJR
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

British Journal of Radiology (2005) 78, 328-334
© 2005 British Institute of Radiology
doi: 10.1259/bjr/22554286

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aznar, M C
Right arrow Articles by Mattsson, S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aznar, M C
Right arrow Articles by Mattsson, S

Full Paper

In vivo absorbed dose measurements in mammography using a new real-time luminescence technique

M C Aznar, MSc 1 B Hemdal, BSc 2 J Medin, PhD 2 C J Marckmann, PhD 1 C E Andersen, PhD 1 L Bøtter-Jensen, DSc 1 I Andersson, MD, PhD 3 and S Mattsson, PhD 2

1 Radiation Research Department, Risø National Laboratory, DK-4000 Roskilde, Denmark, 2 Department of Medical Radiation Physics, Lund University, Malmö University Hospital, SE 205 02 Malmö, Sweden and 3 Department of Diagnostic Radiology, Lund University, Malmö University Hospital, SE 205 02 Malmö, Sweden

A dosimetry system based on radioluminescence (RL) and optically stimulated luminescence (OSL) from carbon doped aluminium oxide (Al2O3:C) crystals was developed for in vivo absorbed dose measurements in mammography. A small cylindrical crystal of Al2O3:C (diameter 0.48 mm and length 2 mm) was coupled to the end of a 1 mm diameter optical fibre cable. Owing to their small size and characteristic shape, these probes can be placed on the body surface in the field of view during the examination, without compromising the reading of the mammogram. Our new technique was tested with a mammography unit (Siemens Mammomat 3000) and screen–film technique over a range of clinically relevant X-ray energies. The results were compared with those obtained from an ionization chamber usually used for the determination of absorbed dose in mammography. The reproducibility of measurements was around 3% (1 standard deviation) at 4.5 mGy for both RL and OSL data. The dose response was found to be linear between 4.5 mGy and 30 mGy. The energy dependence of the system is around 18% between 23 kV and 35 kV. In vivo measurements were performed during three patient examinations. It was shown that entrance and exit doses could be measured. The presence of the small probes did not significantly interfere with the diagnostic quality of the images. Entrance doses estimated by RL/OSL results agreed within 3% with entrance surface dose values calculated from the ionization chamber measurements. These results indicate a considerable potential for use in routine control and in vivo dose measurements in mammography.




This article has been cited by other articles:


Home page
Radiat Prot DosimetryHome page
C. J. Marckmann, C. E. Andersen, M. C. Aznar, and L. Botter-Jensen
Optical fibre dosemeter systems for clinical applications based on radioluminescence and optically stimulated luminescence from Al2O3:C
Radiat Prot Dosimetry, September 1, 2006; 120(1-4): 28 - 32.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Radiol.Home page
BJR Review of the Year - 2005.
Br. J. Radiol., March 1, 2006; 79(939): 183 - 187.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
BJR DMFR IMAGING  ALL BIR JOURNALS 
Copyright © 2005 by the British Institute of Radiology.